Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis.

Jamieson TA, Brizel DM, Killian JK, Oka Y, Jang HS, Fu X, Clough RW, Vollmer RT, Anscher MS, Jirtle RL.

BMC Cancer. 2003 Feb 13;3:4. Epub 2003 Feb 13.

PMID:
12589712
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.

Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, Prosnitz LR.

Cancer. 2002 Jun 1;94(11):2821-9. Review.

PMID:
12115368
[PubMed - indexed for MEDLINE]
Free Article
3.

Clinical and dosimetric predictors of radiation-induced esophageal toxicity.

Maguire PD, Sibley GS, Zhou SM, Jamieson TA, Light KL, Antoine PA, Herndon JE 2nd, Anscher MS, Marks LB.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):97-103.

PMID:
10477012
[PubMed - indexed for MEDLINE]
4.

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):149-54.

PMID:
9422571
[PubMed - indexed for MEDLINE]
5.

Expression and maturation of the cellular sea receptor, a member of the hepatocyte growth factor (HGF) receptor family of protein tyrosine kinases.

Huff JL, Jelinek MA, Jamieson TA, Parsons JT.

Oncogene. 1996 Jan 18;12(2):299-307.

PMID:
8570207
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk